FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, the Great Room (Rm 1503)  

White Oak Conference Center, Silver Spring, MD 

 

December 12, 2013 

MEETING ROSTER 

 

 
 
DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Karen Abraham-Burrell, PharmD  
Division of Advisory Committee and Consultant Management 
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
                                                                                                  
Erica H. Brittain, PhD 
Mathematical Statistician 
Biostatistics Research Branch 
National Institute of Allergy and Infectious 
Diseases (NIAID) 
National Institutes of Health (NIH) 
Bethesda, Maryland 
  
Diana Hallare, MPH 
(Consumer Representative) 
Visalia, California 

William R. Hiatt, MD, FACP 
Professor of Medicine 
Division of Cardiology 
University of Colorado School of Medicine 
President, Colorado Prevention Center (CPC) 
Clinical Research 
Aurora, Colorado 
 
Robert J. Smith, MD 
(Acting Chairperson) 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
Ocean State Research Institute 
Providence Veterans Administration Medical 
Center 
Providence, Rhode Island 
 
 

ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBER  
(Non-Voting) 
 
Mads F. Rasmussen, MD, PhD 
(Industry Representative) 
Project Vice President 
GLP-1 and Obesity – Global Development 
Novo Nordisk A/S  
Denmark 
 
 

 

Page 1 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, the Great Room (Rm 1503)  

White Oak Conference Center, Silver Spring, MD 

 

 

December 12, 2013 

MEETING ROSTER (cont.) 

 
 
TEMPORARY MEMBERS (Voting) 
 
Barbara D. Berney 
(Patient Representative) 
Rockford, Illinois 
 

Antonio Tito Fojo, MD, PhD 
Senior Investigator and Director Medical 
Oncology Fellowship Program   
Center for Cancer Research 
National Cancer Institute, NIH 
Bethesda Maryland  

Julia Lewis, MD  
Professor of Medicine 
Vanderbilt University  
Nashville, Tennessee  
 

Kevin D. McBryde, MD 
Program Director 
National Institute of Diabetes, Digestive, and 
Kidney Diseases (NIDDKD) 
Office of Minority Health Research 
Coordination, NIH 
Bethesda, Maryland 
 

 

 

Milton Packer, MD 
Gayle and Paul Stoffel Distinguished Chair in 
Cardiology 
Professor and Chair, Department of Clinical 
Sciences 
University of Texas Southwestern Medical 
Center 
Dallas, Texas     
                                       
Abraham Thomas, MD, MPH, FACP 
Division Head 
Endocrinology, Diabetes, Bone & Mineral 
Disorders, Whitehouse Chair in Endocrinology 
Henry Ford Hospital 
Detroit, Michigan   

Peter J. Savage, MD  
Senior Adviser for Clinical Research, 
Division of Diabetes, Endocrinology and 
Metabolism,  
National Institute of Diabetes, Digestive, and 
Kidney Diseases 
National Institute of Health 
Bethesda, Maryland  
 
Miriam Vos, MD, MSPH  
Associate Professor of Pediatrics 
Division of Pediatric Gastroenterology, 
Hepatology and Nutrition 
Emory University School of Medicine 
Research Director, Health4Life Program  
Children’s Healthcare of Atlanta 
Atlanta, Georgia 
 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, the Great Room (Rm 1503)  

White Oak Conference Center, Silver Spring, MD 

 

 

December 12, 2013 

MEETING ROSTER (cont.) 

 

 
TEMPORARY MEMBERS (Voting)  
 
Peter W. F. Wilson, MD 
Professor of Medicine 
Emory University School of Medicine 
Atlanta, Georgia 
 

 
FDA PARTICIPANTS (Non-Voting) 
 
Curtis Rosebraugh, MD 
Director 
Office of Drug Evaluation II (ODE-II) 
Office of New Drugs (OND), CDER, FDA 
 
Jean-Marc Guettier, MDCM 
Director (Acting) 
Division of Metabolism and Endocrinology 
Products (DMEP), ODE-II, OND, CDER, FDA 
 

 

 

Wyndham Wilson, MD 
Senior Investigator and 
Deputy Branch Chief 
Lymphoid Malignancy Branch 
Center for Cancer Research 
National Cancer Institute, NIH 
Bethesda, Maryland  
 
 
 

Frank Pucino, PharmD, MPH 
Clinical Reviewer 
DMEP, ODE-II, CDER, FDA 

Eugenio Andraca-Carrera, PhD 
Mathematical Statistician 
Division of Biometrics VII 
Office of Biostatistics 
Office of Translational Sciences, CDER, FDA 

Page 3 of 3 

